A total of $343 million in private capital was invested in five key biotechnology/therapeutics initiatives for the week ending January 24.
The firms involved were some . . .
Continue Reading With a Free Trial
Unlock this article instantly, along with the rest of our premium content, newsletters and mandate charts.
Already a subscriber? Log in.